October 24 - 25, 2019

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

Boston, USA
5+
Sessions
20+
Speakers
100
Attendees
10+
Networking Hours

With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities. Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, this year’s congress will hold discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation.

users

Learn how adoption of real-world evidence can be accelerated across pharmaceutical industry

users

Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research

users

Understand the impact of innovative real-world evidence partnerships for better data

WHAT TO EXPECT
Sessions

Adopting the Right Methodology for Real-World Evidence

Achieving New Level of Quality Insights from Data

Artificial Intelligence & Blockchain: Gamechanger in Real World Evidence

Strategic Framework & Regulatory Considerations

Breakthrough to Excellent Data Evaluation

Key Highlights

Real-World Evidence Methodologies | FDA’s new strategic framework for use of real-world evidence | Applications of Artificial Intelligence & Blockchain for Real-World Data Analysis | Evaluation of data sources for better patient outcomes | Accelerating adoption of Real-world evidence in the pharmaceutical industry and across

Who Should Attend

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, from Pharmaceutical and Biopharmaceutical companies working in the following departments- Real-World Evidence | Health Economics & Outcomes Research  | Market Access  | Value Access | Clinical Outcomes | Clinical Development | Center for Observational and Real-World Evidence

CONFERENCE AGENDA
STRATEGIC FRAMEWORK & REGULATORY CONSIDERATIONS
BREAKTHROUGH TO EXCELLENT DATA EVALUATION
CONFERENCE SPEAKERS
Advisors
Charles Makin

Charles Makin

Global Head, Real World Evidence Strategy
Biogen, Cambridge

Charles Makin

Global Head, Real World Evidence Strategy
Biogen, Cambridge
Paul Petraro

Paul Petraro

Director Pharmacoepidemiology
Regeneron Pharmaceuticals New York

Paul Petraro

Director Pharmacoepidemiology
Regeneron Pharmaceuticals New York
Brian Sweet

Brian Sweet

Executive Director, Oncology, Real World Evidence
Bristol-Myers Squibb,New York

Brian Sweet

Executive Director, Oncology, Real World Evidence
Bristol-Myers Squibb,New York
Speakers
Vic Spain

Vic Spain

Senior Real World Data Scientist
Genentech, San Francisco

Vic Spain

Senior Real World Data Scientist
Genentech, San Francisco
Hannah Ebben

Hannah Ebben

Marketing Analytics Specialist
Takeda Pharmaceuticals

Hannah Ebben

Marketing Analytics Specialist
Takeda Pharmaceuticals
Rachel Twardowski

Rachel Twardowski

Associate Director, Specialty Analytics
Takeda Pharmaceuticals

Rachel Twardowski

Associate Director, Specialty Analytics
Takeda Pharmaceuticals
David Miller

David Miller

Senior Director and Global head of Epidemiology
UCB

David Miller

Senior Director and Global head of Epidemiology
UCB
Nneka Onwudiwe

Nneka Onwudiwe

PRO/PE Regulatory Review Officer
FDA

Nneka Onwudiwe

PRO/PE Regulatory Review Officer
FDA
Senior Representative

Senior Representative

Syneos Health

Senior Representative

Syneos Health
Senior Representative

Senior Representative

Decision Resources Group

Senior Representative

Decision Resources Group
Sofia Iqbal Kring

Sofia Iqbal Kring

Real World Evidence and Core Clinical Trials Manager
Novo Nordisk

Sofia Iqbal Kring

Real World Evidence and Core Clinical Trials Manager
Novo Nordisk
Gregory Daniel

Gregory Daniel

Deputy Center Director, Duke-Margolis Center for Health Policy
Duke University

Gregory Daniel

Deputy Center Director, Duke-Margolis Center for Health Policy
Duke University
Marla Curran

Marla Curran

Executive Director, Head of Biometrics & Medical Writing
Paratek Pharmaceuticals

Marla Curran

Executive Director, Head of Biometrics & Medical Writing
Paratek Pharmaceuticals
 Valerie (Hastings) Strezsak

Valerie (Hastings) Strezsak

Epidemiologist
Takeda Pharmaceuticals

Valerie (Hastings) Strezsak

Epidemiologist
Takeda Pharmaceuticals
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Swetha Rao Palli

Swetha Rao Palli

Associate Director
Boehringer Ingelheim, New York

Swetha Rao Palli

Associate Director
Boehringer Ingelheim, New York
Jyotsna Kasturi

Jyotsna Kasturi

Associate Director, Real World Evidence Statistics
Teva Pharmaceuticals, New York

Jyotsna Kasturi

Associate Director, Real World Evidence Statistics
Teva Pharmaceuticals, New York
Susan Fish

Susan Fish

Associate Director, Registries and Real-World Data
Celgene, San Francisco

Susan Fish

Associate Director, Registries and Real-World Data
Celgene, San Francisco
Jennifer L. Wong

Jennifer L. Wong

Senior Director, Real World Evidence Strategy & Al
AstraZeneca, Gaithersburg

Jennifer L. Wong

Senior Director, Real World Evidence Strategy & Al
AstraZeneca, Gaithersburg
Alex Mutebi

Alex Mutebi

Director, Global Real World Evidence
Vertex Pharmaceuticals, Boston

Alex Mutebi

Director, Global Real World Evidence
Vertex Pharmaceuticals, Boston
Robert Zambon

Robert Zambon

Real World Evidence and Research Innovation and Te
The Janssen Pharmaceutical Companies of Johnson &

Robert Zambon

Real World Evidence and Research Innovation and Te
The Janssen Pharmaceutical Companies of Johnson &
CJ Farhan Hameed

CJ Farhan Hameed

Senior Director, Global Real World Evidence Center
Pfizer,New York

CJ Farhan Hameed

Senior Director, Global Real World Evidence Center
Pfizer,New York
Brian Sweet

Brian Sweet

Executive Director, Oncology, Real World Evidence
Bristol-Myers Squibb,New York

Brian Sweet

Executive Director, Oncology, Real World Evidence
Bristol-Myers Squibb,New York
Charles Makin

Charles Makin

Global Head, Real World Evidence Strategy
Biogen, Cambridge

Charles Makin

Global Head, Real World Evidence Strategy
Biogen, Cambridge
SPONSORS
Silver Sponsors
example-image

Team DRG

Sponsors & Exhibitors
example-image

Syneos Health™

example-image

Aetion

example-image

COTA

PARTNERS
Supporting Association
example-image

California Life Sciences Association (CLSA)

example-image

EuropaBio

Media Partners
example-image

GEN

example-image

Technology Networks

example-image

SciDoc Publishers

example-image

HealthEconomics.Com

example-image

PharmaTutor

example-image

PharmaVOICE

example-image

Pharma Journalist

LOCATION
Boston, USA
About the Hotel

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
will be held in Boston, USA

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

 You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

 

PAST EVENT GALLERY